Should Trazodone Be First-Line Therapy for Insomnia? A Clinical Suitability Appraisal

Area of Science:

• Sleep Medicine
• Pharmacology
• Clinical Practice Guidelines

Background:

• Trazodone is a commonly prescribed medication for insomnia.
• Recent clinical guidelines question its recommendation for insomnia treatment.

Purpose of the Study:

• To critically review the scientific literature on trazodone as a first-line insomnia treatment.
• To assess expert and healthcare professional opinions on the statement: 'Trazodone should never be used as a first-line medication for insomnia.'

Main Methods:

• Clinical literature appraisal focusing on trazodone's efficacy and safety for insomnia.
• Field surveys distributed to physicians, psychiatrists, and sleep specialists.
• A panel discussion with key opinion leaders to review evidence and opinions.

Main Results:

• The majority of surveyed healthcare professionals disagreed with the statement that trazodone should not be a first-line insomnia treatment.
• However, a majority of the expert panel agreed with the statement, citing limited evidence for trazodone as a first-line agent.

Conclusions:

• The evidence supporting trazodone as a first-line insomnia treatment is limited.
• Expert opinion diverges from general practitioner sentiment regarding trazodone's first-line status for insomnia.